SCHEMBL7876571

SCHEMBL7876571

C[C@H](NSCC(=O)OC(C)(C)C)C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
CCNB2 O95067 1/20 0.33
CCNE2 O96020 1/20 0.33
CDK1 P06493 1/20 0.33
CDK4 P11802 1/20 0.33
CCNB1 P14635 1/20 0.33
CCND1 P24385 1/20 0.33
CCNE1 P24864 1/20 0.33
CDK2 P24941 1/20 0.33
CCNB3 Q8WWL7 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7876569 1.00 CYP2D6 (0.36) CYP2D6KMT2AMEN1GAACCNB2
SCHEMBL2317242 0.73 CYP2D6 (0.39) CYP2D6KMT2AMEN1GAACA1
SCHEMBL2407746 0.73 CYP2D6 (0.39) CYP2D6KMT2AMEN1GAACA1
SCHEMBL1339541 0.73 CYP2D6 (0.39) CYP2D6KMT2AMEN1GAACA1
SCHEMBL28418028 0.73 KMT2A (0.35) KMT2AMEN1GAACA1CA2
SCHEMBL9811730 0.72 CCNB2 (0.37) CYP2D6KMT2AMEN1GAACCNB2
SCHEMBL28651697 0.71 CYP1A2 (0.35) CYP2D6CCNB2CCNE2CDK1CDK4
SCHEMBL15490645 0.70 CYP1A2 (0.42) CYP2D6KMT2AMEN1GAACYP1A2
SCHEMBL3193199 0.70 MEN1 (0.40) CYP2D6KMT2AMEN1GAACA1
SCHEMBL646681 0.70 CYP2D6 (0.37) CYP2D6KMT2AMEN1GAACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329502-B1 VIRICIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS; TREATMENT OF AIDS (ACQUIRED IMMUNE DEFICIENCY SYNDROME) JAPAN ENERGY CORPORATION (JP) 2001-12-11 US disclosed
US-6313094-B1 COMPOSITION FOR INHIBITING HUMAN IMMUNODEFICIENCY VIRUS REPLICATION JAPAN ENERGY CORPORATION (JP) 2001-11-06 US disclosed
EP-0490667-B1 HIV protease inhibitors JAPAN ENERGY CORP (JP) 1999-06-09 EP disclosed
EP-0490667-A2 HIV protease inhibitors JAPAN ENERGY CORPORATION (JP) 1992-06-17 EP disclosed